Ahuja, T., Mgbako, O., Katzman, C., & Grossman, A. (2018). Phenibut (β-phenyl-γ-aminobutyric acid) dependence and management of withdrawal: emerging nootropics of abuse. Case Reports in Psychiatry, 2018, 1–3. doi:10.1155/2018/9864285
Downes, M. A., Berling, I. L., Mostafa, A., Grice, J., Roberts, M. S., & Isbister, G. K. (2015). Acute behavioural disturbance associated with phenibut purchased via an Internet supplier. Clinical Toxicology, 53(7), 636–638. doi:10.3109/15563650.2015.1059945
Hardman, M. I., Sprung, J., & Weingarten, T. N. (2018). Acute phenibut withdrawal: A comprehensive literature review and illustrative case report. Bosnian Journal of Basic Medical Sciences, 2018(3 Dec). doi:10.17305/bjbms.2018.4008
Högberg, L., Szabó, I., & Ruusa, J. (2012). Psychotic symptoms during phenibut (beta-phenyl-gamma-aminobutyric acid) withdrawal. Journal of Substance Use, 18(4), 335–338. doi:10.3109/14659891.2012.668261
Joshi, Y. B., Friend, S. F., Jimenez, B., & Steiger, L. R. (2017). Dissociative intoxication and prolonged withdrawal associated with phenibut. Journal of Clinical Psychopharmacology, 37(4), 478–480. doi:10.1097/jcp.0000000000000731
Jouney, E. A. (2019). Phenibut (β-phenyl-γ-aminobutyric acid): An easily obtainable “dietary supplement” with propensities for physical dependence and addiction. Current Psychiatry Reports, 21(4), 23. doi:10.1007/s11920-019-1009-0
Lapin, I. (2006). Phenibut (β-phenyl-GABA): A tranquilizer and nootropic drug. CNS Drug Reviews, 7(4), 471–481. doi:10.1111/j.1527-3458.2001.tb00211.x
Magsalin, R. M. M., & Khan, A. Y. (2010). Withdrawal symptoms after internet purchase of phenibut (β-phenyl-γ-aminobutyric acid HCl). Journal of Clinical Psychopharmacology, 30(5), 648–649. doi:10.1097/JCP.0b013e3181f057c8
Merchan, C. (2016). Phenibut overdose in combination with fasoracetam: Emerging drugs of abuse. Journal of Clinical Intensive Care and Medicine(1), 014–020. doi:10.29328/journal.jcicm.1001001
O'Connell, C. W., Schneir, A. B., Hwang, J. Q., & Cantrell, F. L. (2014). Phenibut, the appearance of another potentially dangerous product in the United States. American Journal of Medicine, 127(8), e3–e4. doi:10.1016/j.amjmed.2014.03.029
Owen, D. R., Wood, D. M., Archer, J. R. H., & Dargan, P. I. (2016). Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review, 35(5), 591–596. doi:10.1111/dar.12356
Samokhvalov, A. V., Paton-Gay, C. L., Balchand, K., & Rehm, J. (2013). Phenibut dependence. Case Reports, 2013, bcr2012008381–bcr2012008381. doi:10.1136/bcr-2012-008381
Sankary, S., Canino, P., & Jackson, J. (2017). Phenibut overdose. American Journal of Emergency Medicine, 35(3), 516.e511–516.e512. doi:10.1016/j.ajem.2016.08.067